Edition:
United Kingdom

Alkem Laboratories Ltd (ALKE.NS)

ALKE.NS on National Stock Exchange of India

2,010.35INR
14 Aug 2018
Change (% chg)

Rs9.85 (+0.49%)
Prev Close
Rs2,000.50
Open
Rs2,024.60
Day's High
Rs2,035.00
Day's Low
Rs1,980.00
Volume
69,212
Avg. Vol
45,476
52-wk High
Rs2,469.00
52-wk Low
Rs1,683.05

Chart for

About

Alkem Laboratories Limited is a pharmaceutical company. The Company is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products. The Company operates through two segments: pharmaceutical and investing. The Company produces generics, generic drugs, active pharmaceutical ingredients (APIs) and... (more)

Overall

Beta: --
Market Cap(Mil.): Rs221,380.59
Shares Outstanding(Mil.): 119.57
Dividend: 9.00
Yield (%): 0.81

Financials

  ALKE.NS Industry Sector
P/E (TTM): 30.54 30.93 32.76
EPS (TTM): 60.62 -- --
ROI: -- 15.07 14.61
ROE: -- 16.59 16.33

India's Alkem Labs gets USFDA report about Amaliya unit

India's Alkem Labs Ltd said on Wednesday the United States Food and Drug Administration (USFDA) has issued a report about its Amaliya facility, citing 13 observations following an inspection.

28 Mar 2018

India's Alkem Labs gets USFDA report about Amaliya unit

March 28 India's Alkem Labs Ltd said on Wednesday the United States Food and Drug Administration (USFDA) has issued a report about its Amaliya facility, citing 13 observations following an inspection.

28 Mar 2018

BRIEF-Alkem Laboratories Gets Form 483 With 13 Observations After U.S. FDA Inspection At Co's Amaliya Facility​

* GOT A FORM 483 WITH 13 OBSERVATIONS AFTER US FDA INSPECTION AT CO'S MANUFACTURING FACILITY AT AMALIYA, DAMAN​

28 Mar 2018

Earnings vs. Estimates